Financial Summary (All financials)
| In millions, except per share items | Jan-31-17 | Jan-31-16 | Jan-31-15 | Jan-31-14 | Jan-31-13 | Jan-31-12 | Jan-31-11 |
| Revenues | 402.6 | 322.2 | 227.7 | 125.7 | 53.8 | 14.0 | 1.7 |
| Revenue growth | 24.9% | 41.5% | 81.1% | 133.5% | 284.2% | 733.6% | |
| Cost of goods sold | 145.7 | 112.6 | 79.0 | 44.2 | 20.5 | 6.3 | 0.8 |
| Gross profit | 256.9 | 209.6 | 148.7 | 81.5 | 33.4 | 7.7 | 0.8 |
| Gross margin | 63.8% | 65.0% | 65.3% | 64.8% | 62.0% | 55.2% | 50.4% |
| Sales and marketing | 254.9 | 198.0 | 143.6 | 75.1 | 39.9 | 12.9 | 2.9 |
| Research and development | 116.2 | 94.0 | 70.3 | 35.2 | 16.1 | 7.9 | 4.4 |
| General and administrative | 42.4 | 36.2 | 30.9 | 13.7 | 5.2 | 3.8 | 0.3 |
| EBITA | -156.4 | -118.6 | -96.1 | -42.6 | -27.8 | -16.8 | -6.8 |
| EBITA margin | -38.8% | -36.8% | -42.2% | -33.9% | -51.6% | -119.8% | -406.1% |
| Amortization of intangibles | 0.2 | | | | | | |
| EBIT | -156.6 | -118.6 | -96.1 | -42.6 | -27.8 | -16.8 | -6.8 |
| EBIT margin | -38.9% | -36.8% | -42.2% | -33.9% | -51.6% | -119.8% | -406.1% |
| Pre-tax income | -157.0 | -119.1 | -98.0 | -42.7 | -27.8 | -16.8 | -6.8 |
| Income taxes | 1.3 | 1.0 | 0.8 | 0.4 | 0.1 | 0.0 | 0.0 |
| Tax rate | | | | | | | 0.0% |
| Net income | -158.3 | -120.1 | -98.8 | -43.2 | -27.9 | -16.8 | -6.8 |
| Net margin | -39.3% | -37.3% | -43.4% | -34.3% | -51.8% | -120.0% | -406.8% |
| |
| Diluted EPS | ($1.85) | ($1.52) | ($1.37) | ($1.61) | ($1.53) | ($1.04) | ($0.47) |
| Shares outstanding (diluted) | 85.5 | 78.9 | 72.3 | 26.8 | 18.2 | 16.2 | 14.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|